Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 1
2009 1
2013 1
2014 4
2015 2
2016 1
2017 2
2018 2
2019 2
2020 3
2021 2
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab in previously untreated melanoma without BRAF mutation.
Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Arance A, Schmidt H, Schadendorf D, Gogas H, Lundgren-Eriksson L, Horak C, Sharkey B, Waxman IM, Atkinson V, Ascierto PA. Robert C, et al. Among authors: charles j. N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16. N Engl J Med. 2015. PMID: 25399552 Free article. Clinical Trial.
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma.
Robert C, Long GV, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Rutkowski P, Hassel JC, McNeil CM, Kalinka EA, Lebbé C, Charles J, Hernberg MM, Savage KJ, Chiarion-Sileni V, Mihalcioiu C, Mauch C, Arance A, Cognetti F, Ny L, Schmidt H, Schadendorf D, Gogas H, Zoco J, Re S, Ascierto PA, Atkinson V. Robert C, et al. Among authors: charles j. J Clin Oncol. 2020 Nov 20;38(33):3937-3946. doi: 10.1200/JCO.20.00995. Epub 2020 Sep 30. J Clin Oncol. 2020. PMID: 32997575 Free PMC article. Clinical Trial.
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.
Ascierto PA, Long GV, Robert C, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Savage KJ, Hernberg MM, Lebbé C, Charles J, Mihalcioiu C, Chiarion-Sileni V, Mauch C, Cognetti F, Ny L, Arance A, Svane IM, Schadendorf D, Gogas H, Saci A, Jiang J, Rizzo J, Atkinson V. Ascierto PA, et al. Among authors: charles j. JAMA Oncol. 2019 Feb 1;5(2):187-194. doi: 10.1001/jamaoncol.2018.4514. JAMA Oncol. 2019. PMID: 30422243 Free PMC article. Clinical Trial.
Developing a multidisciplinary rehabilitation package following hip fracture and testing in a randomised feasibility study: Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR).
Williams NH, Roberts JL, Din NU, Charles JM, Totton N, Williams M, Mawdesley K, Hawkes CA, Morrison V, Lemmey A, Edwards RT, Hoare Z, Pritchard AW, Woods RT, Alexander S, Sackley C, Logan P, Wilkinson C, Rycroft-Malone J. Williams NH, et al. Among authors: charles jm. Health Technol Assess. 2017 Aug;21(44):1-528. doi: 10.3310/hta21440. Health Technol Assess. 2017. PMID: 28836493 Free PMC article. Clinical Trial.
There were minimal differences in most outcomes between the two groups, including the BADL index, with an adjusted mean difference of 0.5 (Cohen's d = 0.29). The intervention group showed a medium-sized improvement on the NEADL scale relative to the control group, with an …
There were minimal differences in most outcomes between the two groups, including the BADL index, with an adjusted mean difference of 0.5 (C …
The spectrum of syncope.
Schraeder PL, Lathers CM, Charles JB. Schraeder PL, et al. Among authors: charles jb. J Clin Pharmacol. 1994 May;34(5):454-9. doi: 10.1002/j.1552-4604.1994.tb04986.x. J Clin Pharmacol. 1994. PMID: 8089256 Review.
Although arising suddenly from prolonged recumbency or returning from weightlessness to Earth's gravity can result in syncope from orthostatic or vasovagal effects, there are many other possible causes. ...The most important screening tool in identifying the mechanism(s …
Although arising suddenly from prolonged recumbency or returning from weightlessness to Earth's gravity can result in syncope from or …
[Mechanisms of resistance to anti-BRAF treatments].
Charles J, Martel C, de Fraipont F, Leccia MT, Robert C, Busser B. Charles J, et al. Ann Dermatol Venereol. 2014 Nov;141(11):671-81. doi: 10.1016/j.annder.2014.06.021. Epub 2014 Aug 7. Ann Dermatol Venereol. 2014. PMID: 25442471 Review. French.
Assessing the efficacy of coproduction to better understand the barriers to achieving sustainability in NHS chronic kidney services and create alternate pathways.
Mc Laughlin L, Williams G, Roberts G, Dallimore D, Fellowes D, Popham J, Charles J, Chess J, Williams SH, Mathews J, Howells T, Stone J, Isaac L, Noyes J. Mc Laughlin L, et al. Among authors: charles j. Health Expect. 2022 Apr;25(2):579-606. doi: 10.1111/hex.13391. Epub 2021 Dec 28. Health Expect. 2022. PMID: 34964215 Free PMC article.
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.
Dahir K, Zanchetta MB, Stanciu I, Robinson C, Lee JY, Dhaliwal R, Charles J, Civitelli R, Roberts MS, Krolczyk S, Weber T. Dahir K, et al. Among authors: charles j. J Endocr Soc. 2021 Jun 2;5(9):bvab099. doi: 10.1210/jendso/bvab099. eCollection 2021 Sep 1. J Endocr Soc. 2021. PMID: 34286168 Free PMC article.
Functional and anatomical imaging are essential to locate the FGF23-secreting tumor(s) causing TIO. Surgical resection is often a curative treatment when the tumor can be localized; however, better management of patients who cannot be operated on with targeted therapies is …
Functional and anatomical imaging are essential to locate the FGF23-secreting tumor(s) causing TIO. Surgical resection is often a cur …
Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.
Commons RJ, Charles J, Cheney J, Lynar SA, Malone M, Raby E; Australian Diabetes-related Foot Disease Guidelines & Pathways Project. Commons RJ, et al. Among authors: charles j. J Foot Ankle Res. 2022 Jun 9;15(1):47. doi: 10.1186/s13047-022-00545-4. J Foot Ankle Res. 2022. PMID: 35676695 Free PMC article.
23 results